T1	intervention 19 28	Cocculine
T2	condition 52 79	chemotherapy-induced emesis
T3	eligibility 740 801	Chemotherapy-naïve patients with non-metastatic breast cancer
T5	outcome-Measure 1174 1186	nausea score
T6	outcome-Measure 1341 1349	vomiting
T7	outcome-Measure 1378 1397	nausea and vomiting
T9	outcome-Measure 1489 1509	treatment compliance
T11	total-participants 1548 1551	431
T12	intervention-participants 1578 1581	214
T13	control-participants 1603 1606	217
T15	cv-bin-abs 1804 1807	103
T16	iv-bin-abs 1836 1839	102
T14	outcome 1868 1890	nausea FLIE scores > 6
T19	outcome 2399 2405	nausea
T20	cv-bin-percent 2410 2415	17.6%
T21	iv-bin-percent 2422 2427	15.7%
T22	outcome 2437 2445	vomiting
T23	cv-bin-percent 2450 2455	10.8%
T24	iv-bin-percent 2462 2467	12.0%
T10	outcome 2337 2362	severe (Grade ≥ 2) nausea
T18	outcome 2367 2375	vomiting
T25	outcome 1695 1705	compliance
T4	control 1610 1621	placebo (P)
T8	outcome 2198 2204	nausea
T17	outcome 2206 2214	vomiting
T26	outcome 2219 2244	global emesis FLIE scores
